Funder
Telomere Diagnostics
National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases
NHLBI and NCI
Health Resources and Services Administration
Office of Naval Research
Actinium Pharmaceuticals, Inc.
Amgen, Inc.
Amneal Biosciences
Angiocrine Bioscience, Inc.
Astellas Pharma US
Atara Biotherapeutics, Inc.
Be the Match Foundation
bluebird bio, Inc.
Bristol Myers Squibb Oncology
Celgene Corporation
Cerus Corporation
Chimerix, Inc.
Fred Hutchinson Cancer Research Center
Gamida Cell Ltd.
Gilead Sciences, Inc.
HistoGenetics, Inc.
Immucor
Incyte Corporation
Janssen Scientific Affairs, LLC
Jazz Pharmaceuticals, Inc.
Juno Therapeutics
Karyopharm Therapeutics, Inc.
Kite Pharma, Inc.
Medac, GmbH
MedImmune
The Medical College of Wisconsin
Merck & Co, Inc.
Mesoblast
MesoScale Diagnostics, Inc.
Millennium, the Takeda Oncology Co.
Miltenyi Biotec, Inc.
National Marrow Donor Program
Neovii Biotech NA, Inc.
Novartis Pharmaceuticals Corporation
Otsuka Pharmaceutical Co, Ltd. – Japan
PCORI
Pfizer, Inc
Pharmacyclics, LLC
PIRCHE AG
Sanofi Genzyme
Seattle Genetics
Shire
Spectrum Pharmaceuticals, Inc.
St. Baldrick's Foundation
Sunesis Pharmaceuticals, Inc.
Swedish Orphan Biovitrum, Inc.
Takeda Oncology
Telomere Diagnostics, Inc.
University of Minnesota
Subject
Transplantation,Hematology